Maria Loustau
Le Vesinet, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 11, 2025
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.
Journal: Cancer immunology research
Published: July 10, 2023
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Journal: Journal for immunotherapy of cancer
Published: February 15, 2021
Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
Journal: Frontiers in immunology
Published: September 21, 2020
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.
Journal: Leukemia
Published: September 03, 2019
Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G.
Journal: Journal of immunology research
Published: March 22, 2019
HLA-G 2012 conference: the 15-year milestone update.
Journal: Tissue antigens
Published: January 26, 2013
Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.
Journal: Cellular and molecular life sciences : CMLS
Published: February 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026